Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3042]

SPRING 01: Exploring the combination of avelumab, axitinib and palbociclib in...

Dr Benjamin M. Solomon - Avera Cancer Institute, Sioux Falls, USA

SPRING 01: Exploring the combination of avelumab, axitinib and palbociclib in patients with advanced metastatic NSCLC ( Dr Benjamin M. Solomon - Avera Cancer Institute, Sioux Falls, USA )

Oncobox, RNA sequencing and molecular pathway analysis-base system for...

Dr Anton Buzdin - Sechenov Moscow First Medical University, Moscow, Russia

Oncobox, RNA sequencing and molecular pathway analysis-base system for prescription of target drugs to advanced cancer patients ( Dr Anton Buzdin - Sechenov Moscow First Medical University, Moscow, Russia )

The value of personalised medicines for healthcare systems in Europe

Anthony Barron - European Biopharmaceutical Enterprises (EBE) and the European...

The value of personalised medicines for healthcare systems in Europe ( Anthony Barron - European Biopharmaceutical Enterprises (EBE) and the European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium )

Decision support for precision oncology: Evolving from monotherapy to...

Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA

Decision support for precision oncology: Evolving from monotherapy to genomically informed combinations ( Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA )

CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast...

Dr Hikmat Abdel-Razeq - King Hussein Cancer Center, Amman, Jordan

CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer ( Dr Hikmat Abdel-Razeq - King Hussein Cancer Center, Amman, Jordan )

Systems immunology in immuno-oncology

Dr Nikesh Kotecha - Parker Institute for Cancer Immunotherapy, San Francisco...

Systems immunology in immuno-oncology ( Dr Nikesh Kotecha - Parker Institute for Cancer Immunotherapy, San Francisco, USA )

Highlights from WIN 2019

Prof Richard Schilsky - Chief Medical Officer of ASCO and WIN Chairman

Highlights from WIN 2019 ( Prof Richard Schilsky - Chief Medical Officer of ASCO and WIN Chairman )

Innovation in clinical trials: WINTHER trial

Prof Razelle Kurzrock - University of California San Diego, San Diego, USA

Innovation in clinical trials: WINTHER trial ( Prof Razelle Kurzrock - University of California San Diego, San Diego, USA )

A precision medicine approach to therapeutic resistance using KEAP1 somatic...

Dr Gerald Batist - McGill University - Segal Cancer Centre, Montreal, Canada

A precision medicine approach to therapeutic resistance using KEAP1 somatic mutations ( Dr Gerald Batist - McGill University - Segal Cancer Centre, Montreal, Canada )

Rapidly changing landscape of precision medicine in Japan

Dr Sadakatsu Ikeda - Tokyo Medical and Dental University, Tokyo, Japan

Rapidly changing landscape of precision medicine in Japan ( Dr Sadakatsu Ikeda - Tokyo Medical and Dental University, Tokyo, Japan )

Direct targeting of STAT3 alone and in combination with immune checkpoint...

Dr David Tweardy - The University of Texas MD Anderson Cancer Center, Houston...

Direct targeting of STAT3 alone and in combination with immune checkpoint inhibitors to treat solid tumours ( Dr David Tweardy - The University of Texas MD Anderson Cancer Center, Houston, USA )

Integration of DNA and RNA investigations in clinical trials: A laboratory...

Brandon Young - Bowden WIN Precision Oncology Laboratory, Murrieta, USA

Integration of DNA and RNA investigations in clinical trials: A laboratory challenge ( Brandon Young - Bowden WIN Precision Oncology Laboratory, Murrieta, USA )

More from ecancer